LONA (LeonaBio) Volatility: 117.44% (As of Jul. 06, 2026)


LONA LeonaBio Inc LONA
28 GF Score
Price $8.80
! 2 Warning Signs
View Full Analysis

What is LeonaBio Volatility?

LeonaBio LONA -0.79% 28 Volatility is 117.44% as of Jul. 06, 2026. GuruFocus rates LONA with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2026-07-06), LeonaBio's Volatility is 117.44%.


LeonaBio  (NAS:LONA) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


LeonaBio Volatility Related Terms


LONA vs ICCC, TELO, PYPD: Volatility Comparison

For the Biotechnology subindustry, LeonaBio's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LeonaBio Volatility vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LeonaBio's Volatility distribution charts can be found below:

* The bar in red indicates where LeonaBio's Volatility falls into.


LONA
28GF Score
LeonaBio Inc LONA
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LeonaBio  (NAS:LONA) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of 117.44% mean?
LeonaBio (LONA) has a Volatility of 117.44% as of Jul. 06, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on LeonaBio and its competitors.
Is LeonaBio's Volatility too high?
LeonaBio's current Volatility is 117.44%. Overall, LeonaBio has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does LeonaBio's Volatility compare to ICCC and TELO?
LeonaBio's Volatility of 117.44% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Biotechnology company?
A good Volatility depends on the Biotechnology industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on LeonaBio and its competitors. LeonaBio's current Volatility is 117.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeonaBio stock overvalued right now?
LeonaBio (LONA) has a current Volatility of 117.44%. The current Volatility is 117.44%. LeonaBio's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For LeonaBio (LONA), the current Volatility is 117.44% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LeonaBio Business Description

Address 18706 North Creek Parkway, Suite 104, Bothell, WA, USA, 98011
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
28GF Score

Get the complete analysis for LONA

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.80
Price